Thromboinflammation in Acute Stroke: From Pathophysiological Challenges to Emerging Therapeutic Opportunities
Stroke · 2026-07 · 57 (7) · 1885-1895
DOI: 10.1161/strokeaha.125.051476 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Stroke, 2026-07. Verfasst von Umberto Pensato und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Humanitas University, Milan, Italy (U.P.). Hauptthemen laut MEDLINE: Stroke, Thromboinflammation, Ischemic Stroke. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 92 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
Despite major advances in intravenous thrombolysis and endovascular thrombectomy, nearly half of patients with acute ischemic stroke fail to achieve functional recovery even after technically successful recanalization. The recanalization-reperfusion gap—the discordance between angiographic vessel opening and tissue-level perfusion recovery—has brought thromboinflammation, the pathological interplay of coagulation and innate immunity, to the forefront of stroke biology. Neutrophil extracellular traps, platelet-leukocyte aggregates, complement activation, and vessel wall inflammation render clots resistant to lysis, promote microvascular obstruction and the no-reflow phenomenon, and amplify ischemia-reperfusion injury. These insights reframe stroke not solely as a problem of reopening arteries, but as an inflammatory disorder in which thrombus biology, microcirculatory flow, and inflammatory injury determine outcome. In this review, we outline the key thromboinflammatory challenges—recanalization resistance, no-reflow, and reperfusion injury—and discuss therapeutic opportunities that emerge from this framework. These include enzymatic neutrophil extracellular traps–targeting, adjunctive anti-inflammatory agents, biomarker-guided precision approaches, and novel device technologies that exploit or mitigate thrombus biology. Collectively, these strategies support a paradigm shift in stroke care: from procedure-focused reperfusion to biologically informed interventions that integrate vascular and immune determinants of outcome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Humanitas University, Milan, Italy (U.P.).
- Department of Neurology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Milan, Italy (U.P.).
- Department of Neurology, Dalhousie University, Halifax, Canada (T.H.).
- Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Canada (A.M.D.).
- INSERM U1148, Laboratory for Vascular Translational Science, Université Paris Cité, France (G.C.).
- Cardiology Department, Assistance Publique-Hôpitaux de Paris, University Hospital Bichat and Beaujon, France (G.C.).
ORCID-Profile: Umberto Pensato, Andrew M Demchuk, Giuseppina Caligiuri
Zitieren
APA
Pensato, U., Henry, T., Demchuk, A. M., & Caligiuri, G. (2026). Thromboinflammation in Acute Stroke: From Pathophysiological Challenges to Emerging Therapeutic Opportunities. Stroke, 57(7), 1885-1895. https://doi.org/10.1161/strokeaha.125.051476
Vancouver
Pensato U, Henry T, Demchuk AM, Caligiuri G. Thromboinflammation in Acute Stroke: From Pathophysiological Challenges to Emerging Therapeutic Opportunities. Stroke. 2026;57(7):1885-1895. doi:10.1161/strokeaha.125.051476
BibTeX
@article{Pensato2026,
author = {Pensato, Umberto and Henry, Tyler and Demchuk, Andrew M and Caligiuri, Giuseppina},
title = {Thromboinflammation in Acute Stroke: From Pathophysiological Challenges to Emerging Therapeutic Opportunities},
journal = {Stroke},
year = {2026},
volume = {57},
number = {7},
pages = {1885--1895},
doi = {10.1161/strokeaha.125.051476}
}
EUVIMED